MindMed adjourns annual meeting due to lack of quorum; accuses FCM of deliberate obstruction

Definium Therapeutics, Inc.

Annual meeting on June 15, 2023 adjourned without business due to absence of required 33⅓% quorum.
Reconvened meeting set for June 21, 2023 at 10:00 a.m. ET; virtual format unchanged.
Company alleges FCM MM Holdings deliberately acted to prevent quorum and shareholder voting.
If quorum still absent at reconvened meeting, attendees present will constitute quorum per Articles.
New proxy deadline June 19, 2023; company urges vote FOR all six Board nominees on WHITE card.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.